Clinical Trial Update: Combination of Alverine-simeticone and i3.1 Probiotic in IBS-D and IBS-M in Mexico [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating a combination of alverine-simeticone and i3.1 probiotic for irritable bowel syndrome (IBS) in Mexico, with completed st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Drugs mentioned

• alverine-simeticone (alverine-simeticone)
• i3.1 probiotic (i3.1 probiotic)

Snippet

Sponsor: Hospital Juarez de Mexico | Conditions: Irritable Bowel Syndrome | Phase 4 | Status: COMPLETED